General Information of This Drug (ID: DM59ZDN)

Drug Name
Nesvacumab   DM59ZDN
Synonyms REGN910; SAR307746
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Antibody

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Nesvacumab + Aflibercept DCDL0DM Aflibercept Diabetic macular edema [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01271972) Study of Nesvacumab (REGN910/ SAR307746). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)